ATE234868T1 - Stabilisator für arzneimittel - Google Patents

Stabilisator für arzneimittel

Info

Publication number
ATE234868T1
ATE234868T1 AT00941031T AT00941031T ATE234868T1 AT E234868 T1 ATE234868 T1 AT E234868T1 AT 00941031 T AT00941031 T AT 00941031T AT 00941031 T AT00941031 T AT 00941031T AT E234868 T1 ATE234868 T1 AT E234868T1
Authority
AT
Austria
Prior art keywords
auxiliary substance
stabilizer
substance
medicinal products
auxiliary
Prior art date
Application number
AT00941031T
Other languages
English (en)
Inventor
Wouter Leonardus Jose Hinrichs
Henderik Willem Frijlink
Original Assignee
Univ Groningen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Groningen filed Critical Univ Groningen
Application granted granted Critical
Publication of ATE234868T1 publication Critical patent/ATE234868T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0051—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Fructofuranans, e.g. beta-2,6-D-fructofuranan, i.e. levan; Derivatives thereof
    • C08B37/0054—Inulin, i.e. beta-2,1-D-fructofuranan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT00941031T 1999-06-11 2000-06-13 Stabilisator für arzneimittel ATE234868T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1012300A NL1012300C2 (nl) 1999-06-11 1999-06-11 Stabilisator voor farmaca.
PCT/NL2000/000405 WO2000078817A1 (en) 1999-06-11 2000-06-13 Stabilizer for pharmacons

Publications (1)

Publication Number Publication Date
ATE234868T1 true ATE234868T1 (de) 2003-04-15

Family

ID=19769360

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00941031T ATE234868T1 (de) 1999-06-11 2000-06-13 Stabilisator für arzneimittel

Country Status (8)

Country Link
US (1) US6841169B2 (de)
EP (1) EP1194453B1 (de)
AT (1) ATE234868T1 (de)
AU (1) AU5579700A (de)
CA (1) CA2375241C (de)
DE (1) DE60001744T2 (de)
NL (1) NL1012300C2 (de)
WO (1) WO2000078817A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
SG114553A1 (en) * 2001-06-29 2005-09-28 Seagate Technology Llc Systems, apparatus, and methods to determine thermal decay characterization from an equalized signal-to-noise ratio of a magnetic disc drive device
PL209134B1 (pl) * 2002-04-03 2011-07-29 Solvay Pharm Bv Sposób wytwarzania kompozycji farmaceutycznej zawierającej naturalny związek kanabinoidowy i kompozycja farmaceutyczna otrzymywana tym sposobem
EP1428526A1 (de) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Zusammensetzung zur schnellen Freisetzung von lipophilen Stoffen
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
JP4851446B2 (ja) * 2004-07-01 2012-01-11 スリーエム イノベイティブ プロパティズ カンパニー ハードコート組成物
TW200621310A (en) * 2004-11-10 2006-07-01 Univ Groningen A process for preparing formulations of lypophilic active substances by spray freeze drying
US20070098864A1 (en) * 2004-11-10 2007-05-03 Zijlstra Gerrit S Process for preparing formulations of lypophilic active substances by spray freezing drying
JP4870944B2 (ja) * 2005-05-23 2012-02-08 弘 竹田 眼薬用組成物
CA2719064C (en) 2008-04-23 2014-02-18 Kim Martha Jozefa Frooninckx Aqueous dispersion of fructan-containing particles, method of preparation and use
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
MX341200B (es) * 2010-03-29 2016-08-11 Ferring Bv Composicion farmaceutica de disolucion rapida.
BR112014005134A2 (pt) * 2011-09-16 2017-04-18 Ferring Bv composição farmacêutica de dissolução rápida
US11116745B2 (en) * 2018-01-31 2021-09-14 Deep Cell Industries, Inc. Prebiotic formulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61181960A (ja) * 1985-02-06 1986-08-14 Daicel Chem Ind Ltd 複合構造物
GB8903593D0 (en) * 1989-02-16 1989-04-05 Pafra Ltd Storage of materials
JPH0341033A (ja) * 1989-07-07 1991-02-21 Kyowa Hakko Kogyo Co Ltd 安定なモチリン類含有製剤
JP2780361B2 (ja) 1989-08-07 1998-07-30 三井化学株式会社 剥離性保護フィルムおよびその組成物
US5250429A (en) * 1991-09-20 1993-10-05 Pharmacia P-L Biochemicals Inc. Glassified restriction enzymes
JP3509148B2 (ja) * 1993-10-07 2004-03-22 明治製菓株式会社 凍害保護剤および凍結保存方法
US5955448A (en) * 1994-08-19 1999-09-21 Quadrant Holdings Cambridge Limited Method for stabilization of biological substances during drying and subsequent storage and compositions thereof
ATE429212T1 (de) * 1995-12-26 2009-05-15 Cns Inc Verabreichungssystem für inulindiätfasern
EP0879600A1 (de) * 1997-05-20 1998-11-25 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Fruktan-haltige Zusammensetzung zur Vorbeugung und Behandlung von Dickdarmkrebs

Also Published As

Publication number Publication date
US6841169B2 (en) 2005-01-11
DE60001744D1 (de) 2003-04-24
WO2000078817A1 (en) 2000-12-28
DE60001744T2 (de) 2004-03-18
CA2375241C (en) 2009-12-22
EP1194453B1 (de) 2003-03-19
EP1194453A1 (de) 2002-04-10
NL1012300C2 (nl) 2000-12-12
US20020122825A1 (en) 2002-09-05
CA2375241A1 (en) 2000-12-28
AU5579700A (en) 2001-01-09

Similar Documents

Publication Publication Date Title
DE60001744D1 (de) Stabilisator für arzneimittel
BRPI0208210B8 (pt) preparação de insulina pobre em zinco e isenta de zinco com estabilidade aperfeiçoada
WO2002094200A3 (en) Pulmonary administration of chemically modified insulin
CA2120942A1 (en) Nitric esters of derivatives of the 2-(2,6-di-halo-phenylamino)phenyl-acetic acid and process for their preparation
BRPI0009299A (pt) formas de administração farmacêuticas mecanicamente estáveis para administração por via oral, e, processo para produzir formas de administração farmacêuticas mecanicamente estáveis.
BR0108354A (pt) Carboidratos antiadesivos
DE69609982D1 (de) Lipopolyamine als transfectionsmittel und ihre pharmazeutischen anwendungen
DE69803940D1 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
SE9801992D0 (sv) New 3-aryl-2-hydroxypropionic acid derivative I
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
RU2002109814A (ru) Новые производные аминодикарбоновых кислот, обладающие фармацевтическими свойствами
IE891032L (en) Pharmaceutical compositions of piroxicam in aqueous solutions and process for their preparation
CA2029524A1 (en) Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
WO1999043361A8 (en) Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
WO2001040240A3 (en) Mono- and disaccharide derivatives
HK102894A (en) Orthorhombic ciclosporin crystal form,process for its production and pharmaceutical compositions containing it
WO1995001168A3 (de) Pharmazeutische zubereitungen, die einen wirkstoff mit modifizierten amidingruppen enthält
DE69033970D1 (de) Huperzin a analoge verbindungen
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
CA2175971A1 (en) Stable liquid composition containing urate oxidase and lyophilized composition for its preparation
TW327602B (en) A pharmaceutical composition of an ophthalmic suspension containing difluprednate
ATE286736T1 (de) Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin
DK0546810T3 (da) Carboxyvinylpolymer med newtonsk viskositet
NO20056241L (no) Nanopartikler av polyoksyetylenerte derivater
KR910005886A (ko) 안정화 백혈구 인터페론

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties